NCT02571257View on ClinicalTrials.gov

Efficacy and Safety of Gemcabene in Hypercholesterolemic Patients on Stable Statin Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
Hypercholesterolemia
Interventions
DRUG

Gemcabene

1-300 mg tablet, QD, 56 days

DRUG

Gemcabene

3-300 mg tablets, QD, 56 days

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

NeuroBo Pharmaceuticals Inc.

INDUSTRY